SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 69,628,559
- Share change
- +3,405,838
- Total reported value
- $1,822,205,095
- Put/Call ratio
- 216%
- Price per share
- $26.22
- Number of holders
- 140
- Value change
- +$89,779,420
- Number of buys
- 80
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stephen P. Squinto |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
6,333,277
mixed-class rows
|
$262,384,838 | — | 19 May 2022 | |
| FMR LLC |
13F
|
Company |
12%
|
9,374,817
|
$237,967,824 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
6%
from 13F
|
5,599,842
|
$232,561,438 | — | 12 Sep 2022 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
13F
|
10%+ Owner · Company |
4.1%
from 13F
|
4,832,413
|
$200,690,112 | — | 10 Aug 2021 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director |
—
mixed-class rows
|
3,105,653
mixed-class rows
|
$128,405,735 | — | 24 May 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
4,408,527
|
$113,475,485 | — | 31 Mar 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
4.6%
|
3,460,208
|
$89,065,754 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
4.5%
|
3,421,541
|
$88,070,000 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
3,244,032
|
$83,501,384 | — | 31 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
4.1%
|
3,100,000
|
$79,794,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
2,811,271
|
$72,362,116 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.6%
|
2,753,502
|
$70,875,141 | — | 31 Mar 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
3.3%
|
2,501,881
|
$64,398,417 | — | 31 Mar 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.8%
|
2,079,352
|
$53,522,520 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.5%
|
1,918,962
|
$49,394,082 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
2.4%
|
1,817,349
|
$46,779,000 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.1%
|
1,579,349
|
$40,652,443 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.9%
|
1,447,389
|
$37,255,793 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.4%
|
1,093,350
|
$28,142,829 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
828,458
|
$21,324,517 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
795,463
|
$20,474,665 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.87%
|
657,865
|
$16,933,446 | — | 31 Mar 2023 | |
| Fiera Capital Corp |
13F
|
Company |
0.81%
|
614,475
|
$15,816,586 | — | 31 Mar 2023 | |
| Finepoint Capital LP |
13F
|
Company |
0.81%
|
614,231
|
$15,810,306 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
558,569
|
$14,377,566 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.68%
|
516,352
|
$13,290,900 | — | 31 Mar 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.64%
|
481,839
|
$12,402,536 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.61%
|
461,037
|
$11,867,092 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.54%
|
407,108
|
$10,479,000 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.53%
|
397,696
|
$10,236,696 | — | 31 Mar 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
350,794
|
$9,029,438 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
340,980
|
$8,776,825 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
327,905
|
$8,440,274 | — | 31 Mar 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.42%
|
317,625
|
$8,175,668 | — | 31 Mar 2023 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.41%
|
312,664
|
$8,047,971 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.41%
|
311,379
|
$8,014,895 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.41%
|
306,545
|
$7,890,468 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.36%
|
273,427
|
$7,039,000 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.35%
|
267,833
|
$6,894,021 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
251,846
|
$6,482,516 | — | 31 Mar 2023 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.32%
|
241,337
|
$6,212,000 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.29%
|
218,829
|
$5,632,658 | — | 31 Mar 2023 | |
| M28 Capital Management LP |
13F
|
Company |
0.26%
|
197,700
|
$5,088,798 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.24%
|
184,334
|
$4,744,759 | — | 31 Mar 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.24%
|
183,546
|
$4,724,474 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
180,442
|
$4,644,577 | — | 31 Mar 2023 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
169,543
|
$4,364,037 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
149,655
|
$3,852,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
127,549
|
$3,283,111 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
127,160
|
$3,273,094 | — | 31 Mar 2023 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2023
As of 30 Jun 2023,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,628,559 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, Deep Track Capital, LP, EcoR1 Capital, LLC, Boxer Capital, LLC, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, and BAKER BROS. ADVISORS LP.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
146
Q2 2023 holders
140
Holder diff
-6
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.